These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Genotypic analysis of Italian MRSA strains exhibiting low-level ceftaroline and ceftobiprole resistance. Bongiorno D; Mongelli G; Stefani S; Campanile F Diagn Microbiol Infect Dis; 2019 Nov; 95(3):114852. PubMed ID: 31288948 [TBL] [Abstract][Full Text] [Related]
5. In vitro activity of ceftaroline and ceftobiprole against methicillin-resistant Staphylococcus aureus with decreased susceptibility to vancomycin isolated in paediatric patients. Carnesecchi G; Lobello R; Liggieri L; Palmero C; Pescetto L; Morelli P; Castagnola E; Bandettini R J Chemother; 2018; 30(6-8):338-341. PubMed ID: 30375268 [TBL] [Abstract][Full Text] [Related]
6. Whole-Genome Sequencing of Methicillin-Resistant Staphylococcus aureus Resistant to Fifth-Generation Cephalosporins Reveals Potential Non-mecA Mechanisms of Resistance. Greninger AL; Chatterjee SS; Chan LC; Hamilton SM; Chambers HF; Chiu CY PLoS One; 2016; 11(2):e0149541. PubMed ID: 26890675 [TBL] [Abstract][Full Text] [Related]
7. Missense mutations of PBP2a are associated with reduced susceptibility to ceftaroline and ceftobiprole in African MRSA. Schaumburg F; Peters G; Alabi A; Becker K; Idelevich EA J Antimicrob Chemother; 2016 Jan; 71(1):41-4. PubMed ID: 26443816 [TBL] [Abstract][Full Text] [Related]
8. High Rate of Ceftobiprole Resistance among Clinical Methicillin-Resistant Morroni G; Brenciani A; Brescini L; Fioriti S; Simoni S; Pocognoli A; Mingoia M; Giovanetti E; Barchiesi F; Giacometti A; Cirioni O Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30275082 [TBL] [Abstract][Full Text] [Related]
9. Reduced In Vitro Activity of Ceftaroline by Etest among Clonal Complex 239 Methicillin-Resistant Staphylococcus aureus Clinical Strains from Australia. Abbott IJ; Jenney AW; Jeremiah CJ; Mirčeta M; Kandiah JP; Holt DC; Tong SY; Spelman DW Antimicrob Agents Chemother; 2015 Dec; 59(12):7837-41. PubMed ID: 26392488 [TBL] [Abstract][Full Text] [Related]
10. Antimicrobial activity of ceftaroline against methicillin-resistant Staphylococcus aureus (MRSA) isolates collected in 2013-2014 at the Geneva University Hospitals. Andrey DO; François P; Manzano C; Bonetti EJ; Harbarth S; Schrenzel J; Kelley WL; Renzoni A Eur J Clin Microbiol Infect Dis; 2017 Feb; 36(2):343-350. PubMed ID: 27744604 [TBL] [Abstract][Full Text] [Related]
11. Activity of ceftaroline versus ceftobiprole against staphylococci and pneumococci in the UK and Ireland: analysis of BSAC surveillance data. Horner C; Mushtaq S; Livermore DM; J Antimicrob Chemother; 2020 Nov; 75(11):3239-3243. PubMed ID: 32728710 [TBL] [Abstract][Full Text] [Related]
12. Ceftaroline Resistance by Clone-Specific Polymorphism in Penicillin-Binding Protein 2a of Methicillin-Resistant Staphylococcus aureus. Lee H; Yoon EJ; Kim D; Kim JW; Lee KJ; Kim HS; Kim YR; Shin JH; Shin JH; Shin KS; Kim YA; Uh Y; Jeong SH Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29941637 [TBL] [Abstract][Full Text] [Related]
13. Characterization of methicillin-resistant Staphylococcus aureus displaying increased MICs of ceftaroline. Mendes RE; Tsakris A; Sader HS; Jones RN; Biek D; McGhee P; Appelbaum PC; Kosowska-Shick K J Antimicrob Chemother; 2012 Jun; 67(6):1321-4. PubMed ID: 22398650 [TBL] [Abstract][Full Text] [Related]